- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02579018
Heart Rate Sensing and Response in Persons With Anorexia Nervosa
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27705
- Duke Medicine - Duke Molecular Physiology Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria: Study participants will include adults with anorexia spectrum disorders and healthy age and gender matched controls. There will be two control groups, one that includes regularly exercising age and gender matched persons and one where controls do not engage in regular exercise.
For those with AN, the following INCLUSION criteria must be met:
- Age ≥ 18 years old
- BMI 25 kg/m2 or less
- Diagnosis of anorexia spectrum disorder
- Medications: Stable use of all medications ≥ three months
For age and gender matched controls, the following INCLUSION criteria must be met:
- Age ≥ 18 years old
- BMI 25 kg/m2 or less
- No diagnosis of anorexia spectrum disorder
- Medications: Stable use of all medications ≥ three months
- Age (+/- 2 years) and gender matched to study participant
Exclusion Criteria:
- History of diabetes, heart disease or taking medications for those conditions
- History of hypertension (high blood pressure) not controlled with medication
- Orthopedic limitations, musculoskeletal disease and/or injury
- Inability to consent
- Lack of transportation to the Duke Center for Living campus
Study Plan
How is the study designed?
Design Details
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Anorexia Nervosa (AN)
Diagnosis of anorexia spectrum disorder and stable use of all medications ≥ three months.
|
All participants will participate in a one hour supervised exercise session.
Participants will wear a physical activity monitor during the assessment for continuous monitoring of heart rate.
Short, intense bouts of exercise will be interspersed with rest periods.
|
|
Experimental: Matched Controls
No diagnosis of anorexia spectrum disorder.
Stable use of all medications ≥ three months.
Also age (+/- 2 years) and gender matched to AN study participant and exercise regularly.
|
All participants will participate in a one hour supervised exercise session.
Participants will wear a physical activity monitor during the assessment for continuous monitoring of heart rate.
Short, intense bouts of exercise will be interspersed with rest periods.
|
|
Experimental: Healthy Controls
No diagnosis of anorexia spectrum disorder.
Stable use of all medications ≥ three months.
Do not exercise regularly.
|
All participants will participate in a one hour supervised exercise session.
Participants will wear a physical activity monitor during the assessment for continuous monitoring of heart rate.
Short, intense bouts of exercise will be interspersed with rest periods.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean percentage of time in prescribed heart rate range during four bouts of interval exercise training
Time Frame: Baseline only
|
One exercise training session
|
Baseline only
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Nancy L Zucker, PhD, Director, Duke Center for Eating Disorders
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00064421
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.